Literature DB >> 23991814

Potential role of stem cells for neuropathic pain disorders.

Sudhakar Vadivelu1, Matthew Willsey, Daniel J Curry, John W McDonald.   

Abstract

Chronic neuropathic pain is a debilitating disease process associated with several medical disorders. Different from pain caused by inflammation, neuropathic pain is a diffuse pain disorder often found to be recalcitrant to the limited medical treatments available. Intractable nerve pain may benefit from other therapies capable of longer-lasting pain coverage or greater efficacy. A growing number of reports have emerged suggesting a role for stem cells as a cellular delivery source with neuroprotective agents opposing the effects of nerve damage. Here, the authors review the current experimental therapies examining the use of stem cells for the treatment of neuropathic pain disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23991814     DOI: 10.3171/2013.6.FOCUS13235

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  3 in total

1.  Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.

Authors:  Kelly Barbosa Gama; Dourivaldo Silva Santos; Afrânio Ferreira Evangelista; Daniela Nascimento Silva; Adriano Costa de Alcântara; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares; Cristiane Flora Villarreal
Journal:  Stem Cells Int       Date:  2018-01-30       Impact factor: 5.443

Review 2.  Stem cell therapy in pain medicine.

Authors:  Yong Hee Han; Kyung Hoon Kim; Salahadin Abdi; Tae Kyun Kim
Journal:  Korean J Pain       Date:  2019-10-01

3.  Bioinformatic Analysis of Potential Biomarkers for Spinal Cord-injured Patients with Intractable Neuropathic Pain.

Authors:  Yimin Wang; Fang Ye; Chanyan Huang; Faling Xue; Yingyuan Li; Shaowei Gao; Zeting Qiu; Si Li; Qinchang Chen; Huaqiang Zhou; Yiyan Song; Wenqi Huang; Wulin Tan; Zhongxing Wang
Journal:  Clin J Pain       Date:  2018-09       Impact factor: 3.442

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.